Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

Yoshida, H; Shiratori, Y; Moriyama, M; Arakawa, Y; Ide, T; Sata, M; Inoue, O; Yano, M; Tanaka, M; Fujiyama, S; Nishiguchi, S; Kuroki, T; Imazeki, F; Yokosuka, O; Kinoyama, S; Yamada, G; Omata, M

doi:10.7326/0003-4819-131-3-199908030-00003

Public

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

Shared by NobleBlocks on Aug 3, 1999 • 12:00 AM UTC

Authors:

H Yoshida

Y Shiratori

M Moriyama

Abstract

BACKGROUND: Previous studies on the effect of interferon therapy on the incidence of hepatocellular carcinoma have not sufficiently assessed degree of liver fibrosis, a major risk factor for hepatocellular carcinoma. OBJECTIVE: To evaluate the effect of interferon therapy on incidence of hepatocellu...

Discussions